『Healthtech Talks with Fexingo: Digital Health, Telemedicine, and Medical Software』のカバーアート

Healthtech Talks with Fexingo: Digital Health, Telemedicine, and Medical Software

Healthtech Talks with Fexingo: Digital Health, Telemedicine, and Medical Software

著者： Fexingo
無料で聴く

Every day, a new health technology company claims to reinvent healthcare. Which ones actually improve patient outcomes, and which are just repackaging old inefficiencies with better user interfaces? In Healthtech Talks with Fexingo, Lucas and Luna cut through the hype to examine the real economics and clinical evidence behind digital health, telemedicine, and medical software. They analyze specific companies — from telemedicine platforms like Teladoc to AI diagnostic tools from Aidoc — dissecting their business models, regulatory hurdles, and adoption curves. Lucas brings a journalist's precision to revenue numbers, clinical trial data, and policy changes (e.g., FDA digital health guidance, CMS telehealth reimbursement rules). Luna challenges assumptions about scalability, patient privacy, and equity of access, grounded in real-world case studies like Babylon Health's rise and fall or the integration of Epic Systems across hospital networks. Each episode focuses on a single topic: how remote patient monitoring platforms affect readmission rates, whether AI scribes actually reduce physician burnout, why some digital therapeutics succeed while others fail FDA clearance. This show is for healthcare executives, venture investors, clinicians evaluating tools, and policy analysts who want substance over slogans. Lucas and Luna don't do 'will robots replace doctors' speculation; they ask: What is the unit economics of a virtual primary care visit? Which medical specialties are most ripe for software disruption? And when will the evidence catch up to the pitch deck? #HealthtechTalks #DigitalHealth #Telemedicine #MedicalSoftware #HealthIT #FexingoBusiness #BusinessPodcast #Technology #HealthcareInnovation #HealthPolicy #AIinHealthcare #RemotePatientMonitoring #DigitalTherapeutics #ValueBasedCare #EpicSystems #Teladoc #Aidoc #BabylonHealth Keep every episode free: buymeacoffee.com/fexingo© 2026 Fexingo. All rights reserved. 経済学
エピソード
  • How Hospital Supply Chains Survived the AI Disruption

    How Hospital Supply Chains Survived the AI Disruption
    2026/09/09
    We examine how leading hospital systems used predictive inventory algorithms to slash waste during recent supply chain volatility. Lucas and Luna break down the specific operational shifts in procurement software, the hidden costs of digital fragmentation, and why data integration remains the hardest hurdle for healthtech builders. #HealthTech #HospitalSupplyChain #DigitalHealth #ProcurementSoftware #InventoryManagement #AIInHealthcare #MedicalDevices #OperationalEfficiency #FexingoBusiness #BusinessPodcast #LunaAndLucas #HealthcareEconomics #TechStartups #DataIntegration #MedicalWaste #SupplyChainResilience #ClinicalOperations #HealthTechNews Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    9 分
  • Why Digital Health Startups Fail at Reimbursement

    Why Digital Health Startups Fail at Reimbursement
    2026/09/08
    Most digital health companies die not because their technology is bad, but because they cannot get paid. We look at the specific mechanics of reimbursement codes, why payers reject novel software, and how successful founders structure their business models to survive the long sales cycle. This episode breaks down the hidden friction in getting medical software covered by insurance. #DigitalHealth #ReimbursementCodes #HealthTechStartups #PayerRelations #MedicalSoftware #CPTCodes #ValueBasedCare #HealthcareFinance #FexingoBusiness #BusinessPodcast #StartupStrategy #HealthcareInnovation #ClinicalWorkflow #MedicareCoverage #PrivatePayors #HealthIT #Commercialization #LucasAndLuna Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    12 分
  • How Digital Therapeutics Are Rewriting Chronic Disease Rules

    How Digital Therapeutics Are Rewriting Chronic Disease Rules
    2026/09/07
    We dig into the specific mechanics of prescription digital therapeutics, focusing on a real-world case study involving Type 2 diabetes management. Unlike general wellness apps, these are FDA-cleared software programs that treat diseases with clinical evidence. We break down how a major payer system integrated a specific blood-sugar coaching platform, reducing hospital readmissions by nearly eighteen percent in its first year. The conversation explores the reimbursement models that make this viable for providers and patients alike, moving beyond the hype to look at the actual data driving adoption. You will learn why insurers are finally writing checks for code instead of pills, and what this means for the future of chronic care management. This is not just about tracking steps; it is about treating pathology with precision software. #DigitalTherapeutics #ChronicDiseaseManagement #HealthTechBusiness #FDAclearedSoftware #TelemedicineInnovation #DiabetesCare #PayerReimbursement #ClinicalEvidence #PatientOutcomes #HealthcareEconomics #MedicalSoftware #PreventiveCare #FexingoBusiness #BusinessPodcast #LucasAndLuna #HealthDataAnalytics #InsurtechTrends #ValueBasedCare Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    10 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません